BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Clinical Outcome
5 results:

  • 1. Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases.
    Veltri A; Garetto I; Tosetti I; Busso M; Volpe A; Pacchioni D; Bollito E; Papotti M
    Eur Radiol; 2011 Feb; 21(2):393-401. PubMed ID: 20809129
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multimodal approach to the management of metastatic epidural spinal cord compression (MESCC) due to solid tumors.
    Tancioni F; Navarria P; Lorenzetti MA; Pedrazzoli P; Masci G; Mancosu P; Alloisio M; Morenghi E; Santoro A; Rodriguez y Baena R; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1467-73. PubMed ID: 20231072
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Therapeutic transarterial embolisation in the management of benign and malignant renal conditions.
    Somani BK; Nabi G; Thorpe P; Hussey J; McClinton S
    Surgeon; 2006 Dec; 4(6):348-52. PubMed ID: 17152199
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology?
    Langner C; Ratschek M; Rehak P; Tsybrovskyy O; Zigeuner R
    BJU Int; 2005 Feb; 95(3):310-4. PubMed ID: 15679784
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increased LAK and T cell activation in responding renal cell carcinoma patients after low dose cyclophosphamide, IL-2 and alpha-IFN.
    Wersäll P; Mellstedt H
    Med Oncol; 1995 Jun; 12(2):69-77. PubMed ID: 8535664
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.